Iñaki F Trocóniz (Iñaki F Troconiz, Iñaki Trocóniz)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Venues

CPT: pharmacometrics & systems pharmacology

Blood advances

Clinical pharmacokinetics

Clinical pharmacology and therapeutics

University of Navarra (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Navarra Aug 01 1988 - Mar 13 1991

Spain

PHD :: School of Pharmacy

Publications

Mario Andrés Sánchez-Salinas, Marta Miarons, Iñaki F Trocóniz, Víctor Navarro, Javier Varela, Gloria Iacoboni, Pere Barba
Is estimated exposure an accurate surrogate for measured fludarabine levels in CAR T-cell patients? Blood advances (2024)
Mario Andrés Sánchez-Salinas, Marta Miarons, Iñaki F Trocóniz, Víctor Navarro, Javier Varela, Gloria Iacoboni, Pere Barba
Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy? Blood advances 8 (9) (2024)
Bruna Bernar Dias, Fernando O Carreño, Victória Etges Helfer, Laura Ben Olivo, Keli Jaqueline Staudt, Karina Paese, Fabiano Barreto, Fabíola Schons Meyer, Ana Paula Herrmann, Sílvia Stanisçuaski Guterres, Stela Maris Kuze Rates, Bibiana Verlindo de Araujo, Iñaki F Trocóniz, Teresa Dalla Costa
Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Bruna Bernar Dias, Fernando O Carreño, Victória Etges Helfer, Laura Ben Olivo, Keli Jaqueline Staudt, Karina Paese, Fabiano Barreto, Fabíola Schons Meyer, Ana Paula Herrmann, Sílvia Stanisçuaski Guterres, Stela Maris Kuze Rates, Bibiana Verlindo de Araujo, Iñaki F Trocóniz, Teresa Dalla Costa
Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Bruna Bernar Dias, Fernando O Carreño, Victória Etges Helfer, Laura Ben Olivo, Keli Jaqueline Staudt, Karina Paese, Fabiano Barreto, Fabíola Schons Meyer, Ana Paula Herrmann, Sílvia Stanisçuaski Guterres, Stela Maris Kuze Rates, Bibiana Verlindo de Araujo, Iñaki F Trocóniz, Teresa Dalla Costa
Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Mario Andrés Sánchez-Salinas, Marta Miarons, Iñaki F Trocóniz, Víctor Navarro, Javier Varela, Gloria Iacoboni, Pere Barba
Is estimated exposure an accurate surrogate for measured fludarabine levels in CAR T-cell patients? Blood advances (2024)
Bruna Bernar Dias, Fernando O Carreño, Victória Etges Helfer, Laura Ben Olivo, Keli Jaqueline Staudt, Karina Paese, Fabiano Barreto, Fabíola Schons Meyer, Ana Paula Herrmann, Sílvia Stanisçuaski Guterres, Stela Maris Kuze Rates, Bibiana Verlindo de Araujo, Iñaki F Trocóniz, Teresa Dalla Costa
Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats. CPT: pharmacometrics & systems pharmacology (2024)
Aymara Sancho-Araiz, Zinnia P Parra-Guillen, Iñaki F Trocóniz, Tomoko Freshwater
Disentangling Anti-Tumor Response of Immunotherapy Combinations: A Physiologically Based Framework for V937 Oncolytic Virus and Pembrolizumab. Clinical pharmacology and therapeutics (2024)
Bruna Bernar Dias, Fernando O Carreño, Victória Etges Helfer, Laura Ben Olivo, Keli Jaqueline Staudt, Karina Paese, Fabiano Barreto, Fabíola Schons Meyer, Ana Paula Herrmann, Sílvia Stanisçuaski Guterres, Stela Maris Kuze Rates, Bibiana Verlindo de Araujo, Iñaki F Trocóniz, Teresa Dalla Costa
Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Bruna Bernar Dias, Fernando O Carreño, Victória Etges Helfer, Laura Ben Olivo, Keli Jaqueline Staudt, Karina Paese, Fabiano Barreto, Fabíola Schons Meyer, Ana Paula Herrmann, Sílvia Stanisçuaski Guterres, Stela Maris Kuze Rates, Bibiana Verlindo de Araujo, Iñaki F Trocóniz, Teresa Dalla Costa
Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Mario Andrés Sánchez-Salinas, Marta Miarons, Iñaki F Trocóniz, Víctor Navarro, Javier Varela, Gloria Iacoboni, Pere Barba
Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy? Blood advances 8 (9) (2024)
Aymara Sancho-Araiz, Zinnia P Parra-Guillen, Jean Bragard, Sergio Ardanza, Victor Mangas-Sanjuan, Iñaki F Trocóniz
Mechanistic characterization of oscillatory patterns in unperturbed tumor growth dynamics: The interplay between cancer cells and components of tumor microenvironment. PLoS computational biology 19 (10) (2023)
Natalia Riva, Lucas Brstilo, Aymara Sancho-Araiz, Manuel Molina, Andrea Savransky, Georgina Roffé, Marianela Sanz, Silvia Noemi Tenembaum, Maria M Katsicas, Iñaki F Trocóniz, Paula S Schaiquevich
Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune Diseases. Pharmaceutics 15 (11) (2023)
Zinnia P Parra-Guillen, Aymara Sancho-Araiz, Kapil Mayawala, Sara Zalba, Maria J Garrido, Dinesh de Alwis, Iñaki F Trocóniz, Tomoko Freshwater
Assessment of clinical response to V937 oncolytic virus after intravenous or intratumoral administration using physiologically-based modelling. Clinical pharmacology and therapeutics (2023)
Johannes van Niel, Petra Bloms-Funke, Ombretta Caspani, Jose Maria Cendros, Luis Garcia-Larrea, Andrea Truini, Irene Tracey, Sonya C Chapman, Nicolás Marco-Ariño, Iñaki F Trocóniz, Keith Phillips, Nanna Brix Finnerup, André Mouraux, Rolf-Detlef Treede
Pharmacological Probes to Validate Biomarkers for Analgesic Drug Development. International journal of molecular sciences 23 (15) (2022)
Diego Vera-Yunca, Karol M Córdoba, Zinnia P Parra-Guillen, Daniel Jericó, Antonio Fontanellas, Iñaki F Trocóniz
Mechanistic modelling of enzyme-restoration effects of new recombinant liver-targeted proteins in acute intermittent porphyria. British journal of pharmacology 179 (14) (2022)
Aymara Sancho-Araiz, Sara Zalba, María J Garrido, Pedro Berraondo, Brian Topp, Dinesh de Alwis, Zinnia P Parra-Guillen, Victor Mangas Sanjuan, Iñaki F Trocóniz
Semi-Mechanistic Model for the Antitumor Response of a Combination Cocktail of Immuno-Modulators in Non-Inflamed (Cold) Tumors. Cancers 13 (20) (2021)
Belen P Solans, María Jesús Garrido, Iñaki F Trocóniz
Drug Exposure to Establish Pharmacokinetic-Response Relationships in Oncology. Clinical pharmacokinetics 59 (2) (2021)
Sara Zalba, Virginia Belsúe, Brian Topp, Dinesh de Alwis, Maite Alvarez, Iñaki F Trocóniz, Pedro Berraondo, María J Garrido
Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1. British journal of cancer 124 (7) (2021)
Diego Vera-Yunca, Zinnia P Parra-Guillen, Pascal Girard, Iñaki F Trocóniz, Nadia Terranova
Relevance of primary lesion location, tumour heterogeneity and genetic mutation demonstrated through tumour growth inhibition and overall survival modelling in metastatic colorectal cancer. British journal of clinical pharmacology (2021)
Aymara Sancho-Araiz, Victor Mangas Sanjuan, Iñaki F Trocóniz
The Role of Mathematical Models in Immuno-Oncology: Challenges and Future Perspectives. Pharmaceutics 13 (7) (2021)
Laura Butragueño Laiseca, Iñaki F Trocóniz, Santiago Grau, Nuria Campillo, Xandra García, Belén Padilla, Sarah N Fernández, Maria José Santiago
Finding the Dose for Ceftolozane-Tazobactam in Critically Ill Children with and without Acute Kidney Injury. Antibiotics (Basel, Switzerland) 9 (12) (2020)
Fernando Carreño, Victória Eteges Helfer, Keli Jaqueline Staudt, Laura Bem Olivo, Karina Paese, Fabíola Schons Meyer, Ana Paula Herrmann, Sílvia Stanisçuaski Guterres, Stela Mari Kuze Rates, Iñaki F Trocóniz, Teresa Dalla Costa
Semi-Mechanistic Pharmacokinetic Modeling of Lipid Core Nanocapsules: Understanding Quetiapine Plasma and Brain Disposition in a Neurodevelopmental Animal Model of Schizophrenia. The Journal of pharmacology and experimental therapeutics 375 (1) (2020)
Itziar Irurzun-Arana, Thomas O McDonald, Iñaki F Trocóniz, Franziska Michor
Pharmacokinetic Profiles Determine Optimal Combination Treatment Schedules in Computational Models of Drug Resistance. Cancer research 80 (16) (2020)
Carlos Fernández-Teruel, Ignacio González-García, Iñaki F Trocóniz, Rubin Lubomirov, Arturo Soto, Salvador Fudio
Population-Pharmacokinetic and Covariate Analysis of Lurbinectedin (PM01183), a New RNA Polymerase II Inhibitor, in Pooled Phase I/II Trials in Patients with Cancer. Clinical pharmacokinetics 58 (3) (2020)
Maria Garcia-Cremades, Nicola Melillo, Iñaki F Trocóniz, Paolo Magni
Mechanistic Multiscale Pharmacokinetic Model for the Anticancer Drug 2',2'-difluorodeoxycytidine (Gemcitabine) in Pancreatic Cancer. Clinical and translational science 13 (3) (2020)
Belén P Solans, Angèle Fleury, Matthias Freiwald, Holger Fritsch, Karin Haug, Iñaki F Trocóniz
Population Pharmacokinetics of Volasertib Administered in Patients with Acute Myeloid Leukaemia as a Single Agent or in Combination with Cytarabine. Clinical pharmacokinetics 57 (3) (2019)
Itziar Irurzun-Arana, Alvaro Janda, Sergio Ardanza-Trevijano, Iñaki F Trocóniz
Optimal dynamic control approach in a multi-objective therapeutic scenario: Application to drug delivery in the treatment of prostate cancer. PLoS computational biology 14 (4) (2018)
Violeta Balbas-Martinez, Leire Ruiz-Cerdá, Itziar Irurzun-Arana, Ignacio González-García, An Vermeulen, José David Gómez-Mantilla, Iñaki F Trocóniz
A systems pharmacology model for inflammatory bowel disease. PloS one 13 (3) (2018)

Iñaki F Trocóniz.css-eqlu8i{font-size:small;padding-left:4px;} (Iñaki F Troconiz, Iñaki Trocóniz)

Publication Activity (10 Years)

Top Topics

Top Venues

Iñaki F Trocóniz (Iñaki F Troconiz, Iñaki Trocóniz)